日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Pharmacological inhibition of sclerostin protects bone from B-cell acute lymphoblastic leukemia-mediated destruction

药物抑制硬骨蛋白可保护骨骼免受B细胞急性淋巴细胞白血病介导的破坏。

Kuek, Vincent; Oommen, Joyce; Ferrari, Emanuela; Yuan, Jinbo; Economides, Aris N; Lock, Richard B; Malinge, Sebastien; Kotecha, Rishi S; Cheung, Laurence C

Pharmacological inhibition of sclerostin protects bone from B‐cell acute lymphoblastic leukemia‐mediated destruction

药物抑制硬骨蛋白可保护骨骼免受B细胞急性淋巴细胞白血病介导的破坏。

Anargyrou, Konstantinos; Fotiou, Despina; Vassilakopoulos, Theodoros P; Christoulas, Dimitrios; Makras, Polyzois; Dimou, Maria; Ntanasis-Stathopoulos, Ioannis; Masouridou, Stavroula; Angelopoulou, Maria K; Papatheodorou, Athanasios; Tsionos, Konstantinos; Panayiotidis, Panayiotis; Dimopoulos, Meletios A; Terpos, Evangelos; Kuek, Vincent; Oommen, Joyce; Ferrari, Emanuela; Yuan, Jinbo; Economides, Aris N; Lock, Richard B; Malinge, Sebastien; Kotecha, Rishi S; Cheung, Laurence C

Inhibition of the NLRP3 inflammasome using MCC950 reduces vincristine-induced adverse effects in an acute lymphoblastic leukemia patient-derived xenograft model

在急性淋巴细胞白血病患者来源的异种移植模型中,使用MCC950抑制NLRP3炎症小体可减轻长春新碱引起的副作用。

Starobova, Hana; McCalmont, Hannah; Shatunova, Svetlana; Tay, Nicolette; Smith, Christopher M; Robertson, Avril; Winkler, Ingrid; Lock, Richard B; Vetter, Irina

Targeting osteoclasts for treatment of high-risk B-cell acute lymphoblastic leukemia

靶向破骨细胞治疗高危B细胞急性淋巴细胞白血病

Kotecha, Rishi S; Trinder, Sarah M; Hughes, Anastasia M; Mullin, Benjamin H; Rashid, Sarah; Yuan, Jinbo; Xu, Jiake; Duncan, Owen; Skut, Patrycja; Chua, Grace-Alyssa; Singh, Sajla; Oommen, Joyce; Lock, Richard B; Kees, Ursula R; Malinge, Sebastien; Kuek, Vincent; Cheung, Laurence C

Precision-guided treatment in high-risk pediatric cancers

高危儿童癌症的精准指导治疗

Lau, Loretta M S; Khuong-Quang, Dong-Anh; Mayoh, Chelsea; Wong, Marie; Barahona, Paulette; Ajuyah, Pamela; Senapati, Akanksha; Nagabushan, Sumanth; Sherstyuk, Alexandra; Altekoester, Ann-Kristin; Fuentes-Bolanos, Noemi A; Yeung, Veronica; Sullivan, Ashleigh; Omer, Natacha; Diamond, Yonatan; Jessop, Sophie; Battaglia, Lauren; Zhukova, Nataliya; Cui, Louise; Lin, Angela; Gifford, Andrew J; Fleuren, Emmy D G; Dalla-Pozza, Luciano; Moore, Andrew S; Khaw, Seong-Lin; Eisenstat, David D; Gottardo, Nicholas G; Wood, Paul J; Tapp, Heather; Alvaro, Frank; McCowage, Geoffrey; Nicholls, Wayne; Hansford, Jordan R; Manoharan, Neevika; Kotecha, Rishi S; Mateos, Marion K; Lock, Richard B; Tyrrell, Vanessa; Haber, Michelle; Trahair, Toby N; Cowley, Mark J; Ekert, Paul G; Marshall, Glenn M; Ziegler, David S

PU.1 eviction at lymphocyte-specific chromatin domains mediates glucocorticoid response in acute lymphoblastic leukemia.

PU.1 在淋巴细胞特异性染色质结构域的移除介导急性淋巴细胞白血病中的糖皮质激素反应

Beck Dominik, Cao Honghui, Tian Feng, Huang Yizhou, Jiang Miao, Zhao Han, Tai Xiaolu, Xu Wenqian, Kosasih Hansen J, Kealy David J, Zhao Weiye, Taylor Samuel J, Couttas Timothy A, Song Gaoxian, Chacon-Fajardo Diego, Walia Yashna, Wang Meng, Dowle Adam A, Holding Andrew N, Bridge Katherine S, Zhang Chao, Wang Jin, Mi Jian-Qing, Lock Richard B, de Bock Charles E, Jing Duohui

Lessons learned from 20 years of preclinical testing in pediatric cancers

从20年的儿科癌症临床前试验中汲取的经验教训

Smith, Malcolm A; Houghton, Peter J; Lock, Richard B; Maris, John M; Gorlick, Richard; Kurmasheva, Raushan T; Li, Xiao-Nan; Teicher, Beverly A; Chuang, Jeffrey H; Dela Cruz, Filemon S; Dyer, Michael A; Kung, Andrew L; Lloyd, Michael W; Mossé, Yael P; Stearns, Timothy M; Stewart, Elizabeth A; Bult, Carol J; Erickson, Stephen W

The third generation AKR1C3-activated prodrug, ACHM-025, eradicates disease in preclinical models of aggressive T-cell acute lymphoblastic leukemia.

第三代 AKR1C3 激活的前药 ACHM-025 可根除侵袭性 T 细胞急性淋巴细胞白血病的临床前模型中的疾病

Toscan Cara E, McCalmont Hannah, Ashoorzadeh Amir, Lin Xiaojing, Fu Zhe, Doculara Louise, Kosasih Hansen J, Cadiz Roxanne, Zhou Anthony, Williams Sarah, Evans Kathryn, Khalili Faezeh, Cai Ruilin, Yeats Kristy L, Gifford Andrew J, Pickford Russell, Mayoh Chelsea, Xie Jinhan, Henderson Michelle J, Trahair Toby N, Patterson Adam V, Smaill Jeff B, de Bock Charles E, Lock Richard B

ETV6::ACSL6 translocation-driven super-enhancer activation leads to eosinophilia in acute lymphoblastic leukemia through IL-3 overexpression

ETV6::ACSL6易位驱动的超级增强子激活通过IL-3过表达导致急性淋巴细胞白血病中嗜酸性粒细胞增多

Xu, Wenqian; Tian, Feng; Tai, Xiaolu; Song, Gaoxian; Liu, Yuanfang; Fan, Liquan; Weng, Xiangqin; Yang, Eunjeong; Wang, Meng; Bornhäuser, Martin; Zhang, Chao; Lock, Richard B; Wong, Jason W H; Wang, Jin; Jing, Duohui; Mi, Jian-Qing

Patient-Specific Circulating Tumor DNA for Monitoring Response to Menin Inhibitor Treatment in Preclinical Models of Infant Leukemia

利用患者特异性循环肿瘤DNA监测婴儿白血病临床前模型中对Menin抑制剂治疗的反应

Doculara, Louise; Evans, Kathryn; Gooding, J Justin; Bayat, Narges; Lock, Richard B